124 related articles for article (PubMed ID: 34875275)
21. Buprenorphine-Clinically useful but often misunderstood.
Butler S
Scand J Pain; 2013 Jul; 4(3):148-152. PubMed ID: 29913911
[TBL] [Abstract][Full Text] [Related]
22. Role of mu-opioid agonist efficacy on antinociceptive interactions between mu agonists and the nociceptin opioid peptide agonist Ro 64-6198 in rhesus monkeys.
Cornelissen JC; Steele FF; Tenney RD; Obeng S; Rice KC; Zhang Y; Banks ML
Eur J Pharmacol; 2019 Feb; 844():175-182. PubMed ID: 30552903
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of multimodal analgesic treatment of severe traumatic acute pain in mice pretreated with chronic high dose of buprenorphine inducing mechanical allodynia.
Coutens B; Derreumaux C; Labaste F; Minville V; Guiard BP; Moulédous L; Bounes V; Roussin A; Frances B
Eur J Pharmacol; 2020 May; 875():172884. PubMed ID: 31870829
[TBL] [Abstract][Full Text] [Related]
24. BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice.
Khroyan TV; Wu J; Polgar WE; Cami-Kobeci G; Fotaki N; Husbands SM; Toll L
Br J Pharmacol; 2015 Jan; 172(2):668-80. PubMed ID: 24903063
[TBL] [Abstract][Full Text] [Related]
25. Toward an effective peripheral visceral analgesic: responding to the national opioid crisis.
Camilleri M
Am J Physiol Gastrointest Liver Physiol; 2018 Jun; 314(6):G637-G646. PubMed ID: 29470146
[TBL] [Abstract][Full Text] [Related]
26. Endogenous and Exogenous Opioids in Pain.
Corder G; Castro DC; Bruchas MR; Scherrer G
Annu Rev Neurosci; 2018 Jul; 41():453-473. PubMed ID: 29852083
[TBL] [Abstract][Full Text] [Related]
27. BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates.
Kiguchi N; Ding H; Cami-Kobeci G; Sukhtankar DD; Czoty PW; DeLoid HB; Hsu FC; Toll L; Husbands SM; Ko MC
Br J Anaesth; 2019 Jun; 122(6):e146-e156. PubMed ID: 30916003
[TBL] [Abstract][Full Text] [Related]
28. Endogenous opiates and behavior: 2014.
Bodnar RJ
Peptides; 2016 Jan; 75():18-70. PubMed ID: 26551874
[TBL] [Abstract][Full Text] [Related]
29. Opioid agonist-antagonist drugs in acute and chronic pain states.
Hoskin PJ; Hanks GW
Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
[TBL] [Abstract][Full Text] [Related]
30. Cebranopadol: A Novel First-in-Class Potent Analgesic Acting via NOP and Opioid Receptors.
Tzschentke TM; Linz K; Koch T; Christoph T
Handb Exp Pharmacol; 2019; 254():367-398. PubMed ID: 30927089
[TBL] [Abstract][Full Text] [Related]
31. Managing long-term high-dose prescription opioids in patients with non-cancer pain: The potential role of sublingual buprenorphine.
Chong J; Frei M; Lubman DI
Aust J Gen Pract; 2020 Jun; 49(6):339-343. PubMed ID: 32464722
[TBL] [Abstract][Full Text] [Related]
32. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
Owusu Obeng A; Hamadeh I; Smith M
Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
[TBL] [Abstract][Full Text] [Related]
33. New Small-molecule Analgesics.
Laev SS; Salakhutdinov NF
Curr Med Chem; 2021; 28(30):6234-6273. PubMed ID: 34126884
[TBL] [Abstract][Full Text] [Related]
34. Opioid and adjuvant analgesics: compared and contrasted.
Khan MI; Walsh D; Brito-Dellan N
Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486
[TBL] [Abstract][Full Text] [Related]
35. Designing safer analgesics: a focus on μ-opioid receptor pathways.
Pergolizzi JV; LeQuang JA; Taylor R; Ossipov MH; Colucci D; Raffa RB
Expert Opin Drug Discov; 2018 Oct; 13(10):965-972. PubMed ID: 30175624
[TBL] [Abstract][Full Text] [Related]
36. Impact of efficacy at the μ-opioid receptor on antinociceptive effects of combinations of μ-opioid receptor agonists and cannabinoid receptor agonists.
Maguire DR; France CP
J Pharmacol Exp Ther; 2014 Nov; 351(2):383-9. PubMed ID: 25194020
[TBL] [Abstract][Full Text] [Related]
37. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
Candiotti KA; Gitlin MC
Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361
[TBL] [Abstract][Full Text] [Related]
38. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
39. Effects of NOP-Related Ligands in Nonhuman Primates.
Kiguchi N; Ko MC
Handb Exp Pharmacol; 2019; 254():323-343. PubMed ID: 30879202
[TBL] [Abstract][Full Text] [Related]
40. A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates.
Ding H; Kiguchi N; Yasuda D; Daga PR; Polgar WE; Lu JJ; Czoty PW; Kishioka S; Zaveri NT; Ko MC
Sci Transl Med; 2018 Aug; 10(456):. PubMed ID: 30158150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
